160 related articles for article (PubMed ID: 31626922)
1. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity.
Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y
Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922
[TBL] [Abstract][Full Text] [Related]
2. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
[TBL] [Abstract][Full Text] [Related]
3. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro.
Zheng S; Löw K; Wagner S; Yang X; von Briesen H; Zou S
Toxicol In Vitro; 2011 Dec; 25(8):1557-67. PubMed ID: 21640813
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles.
Xu L; Chen H; Xu H; Yang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405
[TBL] [Abstract][Full Text] [Related]
6. Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells.
Yao J; Jiang Z; Duan W; Huang J; Zhang L; Hu L; He L; Li F; Xiao Y; Shu B; Liu C
Biol Pharm Bull; 2008 Apr; 31(4):592-7. PubMed ID: 18379047
[TBL] [Abstract][Full Text] [Related]
7. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
[TBL] [Abstract][Full Text] [Related]
8. Triptolide sensitizes liver cancer cell lines to chemotherapy in vitro and in vivo.
Li Y; Hu S
Panminerva Med; 2014 Sep; 56(3):211-20. PubMed ID: 24352031
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney.
Li M; Hu T; Tie C; Qu L; Zheng H; Zhang J
Proteomics; 2017 Nov; 17(22):. PubMed ID: 28895652
[TBL] [Abstract][Full Text] [Related]
10. Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.
Wang J; Zhang ZQ; Li FQ; Chen JN; Gong X; Cao BB; Wang W
Oncol Rep; 2020 Jun; 43(6):1863-1874. PubMed ID: 32236588
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide.
Tian T; Song Y; Li K; Sun Y; Wang Q
Mol Pharm; 2018 Feb; 15(2):560-570. PubMed ID: 29307194
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cancer Angiogenesis Using Triptolide Nanoparticles.
Wang C; Shan Y; Yang J; Xu X; Zhuang B; Fan Y; Xu W
J Biomed Nanotechnol; 2015 May; 11(5):805-15. PubMed ID: 26349393
[TBL] [Abstract][Full Text] [Related]
14. Triptolide-targeted delivery methods.
Xu H; Liu B
Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832
[TBL] [Abstract][Full Text] [Related]
15. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide.
Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J
J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956
[TBL] [Abstract][Full Text] [Related]
16. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C
Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044
[TBL] [Abstract][Full Text] [Related]
17. Effect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis.
Liu M; Dong J; Yang Y; Yang X; Xu H
J Nanosci Nanotechnol; 2008 Jul; 8(7):3493-9. PubMed ID: 19051901
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of the safety of triptolide-loaded hydrogel-thickened microemulsion.
Xu L; Pan J; Chen Q; Yu Q; Chen H; Xu H; Qiu Y; Yang X
Food Chem Toxicol; 2008 Dec; 46(12):3792-9. PubMed ID: 18952137
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii.
Shamon LA; Pezzuto JM; Graves JM; Mehta RR; Wangcharoentrakul S; Sangsuwan R; Chaichana S; Tuchinda P; Cleason P; Reutrakul V
Cancer Lett; 1997 Jan; 112(1):113-7. PubMed ID: 9029176
[TBL] [Abstract][Full Text] [Related]
20. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Yang M; Gu Y; Yang D; Tang X; Liu J
J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
